e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation
Edlmayr J., Niespodziana K., Popow-Kraupp T., Krzyzanek V., Focke-Tejkl M., Blaas D., Grote M., Valenta R.
Source:
Eur Respir J 2011; 37: 44-52
Journal Issue:
January
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Edlmayr J., Niespodziana K., Popow-Kraupp T., Krzyzanek V., Focke-Tejkl M., Blaas D., Grote M., Valenta R.. Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J 2011; 37: 44-52
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Antibody epitope and mimotope prediction of the viroporins M2 of the Influenza A virus, E of the Human SARS coronavirus and SH of the Respiratory Syncytial virus.
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
An anti-human ICAM-1 antibody inhibits human rhinovirus infection in the mouse model of human major group rhinovirus infection
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011
Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Viral infections of the nose and lung
Source: ISSN=1025-448x, ISBN=1-904097-19-16, page=79
Year: 2001
Dual infection of infants by human metapneumovirus (hMPV) and human respiratory syncytial virus (hRSV) is strongly associated with severe bronchiolitis
Source: Annual Congress 2004 - Viral bronchiolitis in children: what's new in diagnosis and treatment?
Year: 2004
RSV and human metapneumovirus – major pathogens of childhood – also adults and the elderly?
Source: Annual Congress 2005 - Major viral threats to the lung
Year: 2005
COVID-19 vaccination and more
Source: ERS webinar 2021: COVID-19 vaccination and more
Year: 2021
LSC 2013 abstract - Mast cells support rhinovirus but not respiratory syncytial virus replication and contribute to the pro-inflammatory response to rhinovirus
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
The role of viruses in chronic bronchitis and exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 68-75
Year: 2013
Potential inhibitors of respiratory syncytial virus (RSV) selected from a phage displayed random peptide library
Source: Eur Respir J 2002; 20: Suppl. 38, 158s
Year: 2002
Responses to rhinovirus infection in human lung slices are reduced by rupintrivir
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Serial viral infections in infants with recurrent respiratory illnesses
Source: Eur Respir J 2008; 32: 314-320
Year: 2008
Efficacy of IFN-λ1 to protect human airway epithelial cells against rhinovirus 1B infection
Source: Annual Congress 2013 –Viral infections
Year: 2013
Viruses in asthma and COPD: mechanisms and defence
Source: Annual Congress 2005 - Microorganisms: good, bad or ugly in allergic respiratory disease
Year: 2005
Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma
Source: Eur Respir J 2002; 19: 68-75
Year: 2002
The effect of influenza virus infection on airway inflammation in a murine model of asthma
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Abortive replication and reactivation in vitro respiratory syncytial virus (RSV) infection in palivizumab-treated HeLa cells
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Long-term derangement of antigen presenting cells in the respiratory tract of mice following influenza virus infection
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept